November 18, 2024 2 min read ...

November 13, 2024 2 min read ...

We commend Yeo et al in their effort to address concerns regarding glucagon-like peptide 1 receptor agonists (GLP-1RA) and the risk of pulmonary aspiration ...

We recommend caution in the interpretation of the study findings/recommendations by Yeo et al on the procedural aspiration risk associated with ...

GLP-1 Receptor Agonists' Role in Reducing Hepatocellular Carcinoma Risk

Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes”

Methodology of Study on GLP-1 Receptor Agonists and Hepatocellular Carcinoma Risk

INTRODUCTION: Inadequate bowel preparation can result in decreased diagnostic accuracy and therapeutic safety of colonoscopy for colon cancer screening. ...

...

Glucagon-like peptide 1 receptor agonists for treatment of steatotic liver disease in patients with Type 2 diabetes mellitus: growing evidence but not yet ...